Experimental Approaches to the Assessment of Potential Cardioprotective Means with Doxorubicin-Associated Cardiomyopathy. Asian Journal of Pharmaceutics (AJP), [S. l.], v. 12, n. 04, 2019. DOI: 10.22377/ajp.v12i04.2943. Disponível em: http://www.asiapharmaceutics.info/index.php/ajp/article/view/2943. Acesso em: 14 apr. 2026.